Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa

J Am Acad Dermatol. 1991 Aug;25(2 Pt 1):332-3. doi: 10.1016/s0190-9622(08)80475-6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • 5-Hydroxytryptophan / adverse effects*
  • Aged
  • Carbidopa / adverse effects*
  • Chronic Disease
  • Depression / drug therapy
  • Drug Therapy, Combination
  • Eosinophilia-Myalgia Syndrome / chemically induced
  • Humans
  • Male
  • Parkinson Disease / drug therapy
  • Scleroderma, Localized / chemically induced*

Substances

  • 5-Hydroxytryptophan
  • Carbidopa